Buls Nico, Pagés Jessica, de Mey Johan, Osteaux Michel
Free University Hospital Brussels (AZ-VUB), Department of Radiology and Medical Imaging, Laarbeeklaan 101, B-1090 Brussels, Belgium.
Health Phys. 2003 Aug;85(2):165-73. doi: 10.1097/00004032-200308000-00005.
As CT scanners are more routinely used as a guidance tool for various types of interventional radiological procedures, concern has grown for high patient and staff doses. CT fluoroscopy provides the physician immediate feedback and can be a valuable tool to dynamically assist various types of percutaneous interventions. However, the fixed position of the scanning plane in combination with high exposure factors may lead to high cumulative patient skin doses that can reach deterministic threshold limits. The staff is also exposed to a considerable amount of scatter radiation while standing next to the patient during the procedures. Although some studies have been published dealing with this subject, data of patient skin doses determined by direct in vivo dosimetry remains scarce. The purpose of this study is to quantify and to evaluate both patient and staff doses by direct thermoluminescent dosimetry during various clinical CT fluoroscopy guided procedures. Patient doses were quantified by determining the entrance skin dose with direct thermoluminescent dosimetry and by estimating the effective dose (E). Staff doses were quantified by determining the entrance skin dose at the level of the eyes, thyroid, and both the hands with direct thermoluminescent dosimetry. For a group of 82 consecutive patients, the following median values were determined (data per procedure): patient E (19.7 mSv), patient entrance skin dose (374 mSv), staff entrance skin dose at eye level (0.21 mSv), thyroid (0.24 mSv), at the left hand (0.18 mSv), and at the right hand (0.76 mSv). The maximum recorded patient entrance skin dose stayed well below the deterministic threshold level of 2 Gy. Poor correlation between both patient/staff doses and integrated procedure mAs emphasizes the need for in vivo measurements. CT fluoroscopy doses are markedly higher than classic CT-scan doses and are comparable to doses from other interventional radiological procedures. They consequently require adequate radiation protection management. An important potential for dose reduction exists by limiting the fluoroscopic screening time and by reducing the tube current (mA) to a level sufficient to provide adequate image quality.
由于CT扫描仪越来越常规地用作各种介入放射学程序的引导工具,人们对患者和工作人员的高剂量辐射愈发担忧。CT透视可为医生提供即时反馈,是动态辅助各类经皮介入操作的宝贵工具。然而,扫描平面的固定位置与高曝光因子相结合,可能导致患者皮肤累积高剂量辐射,甚至可能达到确定性阈值极限。在操作过程中,工作人员站在患者旁边时也会受到大量散射辐射。尽管已经发表了一些关于该主题的研究,但通过直接体内剂量测定法确定的患者皮肤剂量数据仍然稀缺。本研究的目的是通过直接热释光剂量测定法,在各种临床CT透视引导程序中对患者和工作人员的剂量进行量化和评估。通过直接热释光剂量测定法确定入射皮肤剂量并估算有效剂量(E)来量化患者剂量。通过直接热释光剂量测定法确定眼睛、甲状腺以及双手水平的入射皮肤剂量来量化工作人员剂量。对于连续82例患者组成的一组病例,确定了以下中位数(每个程序的数据):患者有效剂量(19.7 mSv)、患者入射皮肤剂量(374 mSv)、工作人员眼睛水平入射皮肤剂量(0.21 mSv)、甲状腺(0.24 mSv)、左手(0.18 mSv)和右手(0.76 mSv)。记录到的患者最大入射皮肤剂量远低于2 Gy的确定性阈值水平。患者/工作人员剂量与综合程序毫安秒之间的相关性较差,这凸显了体内测量的必要性。CT透视剂量明显高于传统CT扫描剂量,与其他介入放射学程序的剂量相当。因此,它们需要适当的辐射防护管理。通过限制透视筛查时间并将管电流(mA)降低到足以提供足够图像质量的水平,存在显著的剂量降低潜力。